LBBW Venture Capital GmbH is a subsidiary of LBBW and represents the „center of competence“ for venture capital investments in leading startups with a high technological edge and product differentiation. Since 1998, we serve the market of venture capital financing in southwest germany. In 2018 we expanded our search focus to the DACH region, where we scout for technology-oriented companies in the fields of life sciences and digital transformation. Overall we invested in more than 50 companies. Our life science investments are: Phenex Pharmaceuticals AG, acousia Therapeutics GmbH, Amcure GmbH, biametrics GmbH, CorTec GmbH.